Innate Pharma
IPHA
#8396
Rank
ยฃ0.13 B
Marketcap
ยฃ1.53
Share price
2.06%
Change (1 day)
-27.83%
Change (1 year)

Revenue for Innate Pharma (IPHA)

Revenue in 2023: ยฃ44.39 Million

According to Innate Pharma 's latest financial reports the company's current revenue (TTM ) is ยฃ44.39 Million. In 2023 the company made a revenue of ยฃ44.39 Million an increase over the revenue in the year 2022 that were of ยฃ41.14 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Innate Pharma from 2005 to 2023

Annual revenue

Year Revenue Change
2023ยฃ44.39 M7.88%
2022ยฃ41.14 M287.78%
2021ยฃ10.61 M-80.14%
2020ยฃ53.44 M-10.13%
2019ยฃ59.46 M-15.91%
2018ยฃ70.71 M133.44%
2017ยฃ30.29 M-33.72%
2016ยฃ45.7 M201.72%
2015ยฃ15.14 M1674.86%
2014ยฃ0.85 M-93.59%
2013ยฃ13.32 M25.45%
2012ยฃ10.62 M41.8%
2011ยฃ7.48 M68.46%
2010ยฃ4.44 M-48.02%
2009ยฃ8.55 M-38.81%
2008ยฃ13.97 M-13.41%
2007ยฃ16.14 M86.54%
2006ยฃ8.65 M286.35%
2005ยฃ2.24 M